Evidence map›Paper›PMID 29565183›Full record

ArticleAIDS patient care and STDs2018

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis.

Jonathan D Fuchs, Kristefer Stojanovski, Eric Vittinghoff, Vanessa M McMahan, Sybill G Hosek, K Rivet Amico, Aminta Kouyate, Hailey J Gilmore, Susan P Buchbinder, Richard T Lester and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05262426 (Optimizing an mHealth Intervention to Improve Uptake and Adherence of the HIV Pre-exposure Prophylaxis), which is not on this map. Cited by 65 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05262426 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

Optimizing an mHealth Intervention to Improve Uptake and Adherence of the HIV Pre-exposure Prophylaxis (PrEP) in Vulnerable Adolescents and Emerging Adults

TypeinterventionalSponsorUniversity of Massachusetts, WorcesterRan2021 to 2026Enrolled145ConditionsPre-Exposure ProphylaxisArmsBehavioral: Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP), Enhanced YaCool, Standard PrEP Counseling
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jonathan D Fuchs1 San Francisco Department of Public Health, San Francisco, California.
Kristefer Stojanovski3 University of Michigan School of Public Health , Ann Arbor, Michigan.
Eric Vittinghoff2 University of California , San Francisco, San Francisco, California.
Vanessa M McMahan4 University of Washington School of Public Health , Seattle, Washington.
Sybill G Hosek5 Stroger Hospital of Cook County , Chicago, Illinois.
K Rivet Amico3 University of Michigan School of Public Health , Ann Arbor, Michigan.
Aminta Kouyate1 San Francisco Department of Public Health, San Francisco, California.
Hailey J Gilmore2 University of California , San Francisco, San Francisco, California.
Susan P Buchbinder1 San Francisco Department of Public Health, San Francisco, California.
Richard T Lester6 University of British Colombia , Vancouver, Canada .
Robert M Grant2 University of California , San Francisco, San Francisco, California.
Albert Y Liu1 San Francisco Department of Public Health, San Francisco, California.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
San Francisco Vaccine and Prevention UnitU01AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2007 to 2011
$7.3M
Chemoprophylaxis and HIV-Host InteractionsR01AI062333 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI GRANT, ROBERT M. · 2004 to 2011
$6.2M
Chemoprophylaxis and HIV Host InteractionsR01AI118575 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANT, ROBERT M. · 2015 to 2019
$2.9M
Enhancing PrEP in Community Settings (EPIC)R01MH095628 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI LIU, ALBERT YING-HWA · 2011 to 2015
$2.4M
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI062333NIAID NIH HHS R01 AI118575NIAID NIH HHS U01 AI069496NIAID NIH HHS UM1 AI069496NIMH NIH HHS R01 MH095628
6 · The paper itself

Abstract

Preexposure prophylaxis is a highly protective HIV prevention strategy, yet nonadherence can significantly reduce its effectiveness. We conducted a mixed methods evaluation of a mobile health intervention (iText) that utilized weekly bidirectional text or e-mail support messages to encourage preexposure prophylaxis (PrEP) adherence among participants in the multi-site iPrEx open-label extension study. A convenience sample of PrEP users from the San Francisco and Chicago sites participated in a 12-week pilot study. Fifty-six men who have sex with men were enrolled; a quarter of them were less than 30 years of age, 13% were black/African American, 11% were Latino, and most (88%) completed some college. Two-thirds opted for text message delivery. Of the 667 messages sent, only 1 individual requested support; initial nonresponse was observed in 22% and was higher among e-mail compared to text message recipients. Poststudy, a majority of participants would recommend the intervention to others, especially during PrEP initiation. Moreover, younger participants and men of color were more likely to report that they would use the iText strategy if it were available to them. Several participants commented that while they were aware that the messages were automated, they felt supported and encouraged that "someone was always there." Study staff reported that the intervention is feasible to administer and can be incorporated readily into clinic flow. A pre-post intervention regression discontinuity analysis using clinic-based pill counts showed a 50% reduction in missed doses [95% confidence interval (CI) 16-71; p = 0.008] and 77% (95% CI 33-92; p = 0.007) when comparing pill counts at quarterly visits just before and after iText enrollment. A mobile health intervention using weekly bidirectional messaging was highly acceptable and demonstrated promising effects on PrEP adherence warranting further evaluation for efficacy in a randomized controlled trial.

Indexed as

Drug MonitoringTelemedicineText MessagingAdultAgedAnti-Retroviral AgentsBlack or African AmericanChicagoHealth PromotionHispanic or LatinoHIV InfectionsHomosexuality, MaleHumansMaleMedication AdherenceMiddle AgedAnti-Retroviral AgentsadherenceHIVmobile healthpreexposure prophylaxistext messaging

Identifiers

PMID29565183
PMCPMC5865612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.